-Homoarginine and cardiovascular disease

Objectives: The main objectives of The Cardiovascular Disease in Norway (CVDNOR) project are 1) to study trends in CVD incidence, prevalence, survival and mortality and 2)

Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all‑cause mortality in type 1 diabetes:

Modifiable cardiovascular disease risk factors among adults in southern Ethiopia: a community- based cross- sectional

LDL-cholesterol (LDL-C) levels are elevated from birth resulting in substantially increased life-long cholesterol burden and increased risk of premature cardiovascular

Association of the aspartate aminotransferase to alanine ami- notransferase ratio with BNP level and cardiovascular mortality in the general population: The Yamagata study

of cycling and walking for travel with diabetes and other risk factors for cardiovascular disease (CVD) 22.. in a multi-ethnic,

Figure 2 Dose–response associations between plasma trimethyllysine and risk of total and cardiovascular mortality in the Hordaland Health Study-cohort (A and C) and Western

1.3.7 CHOLINE METABOLISM IN RELATION TO CVD AND DIABETES Small population studies have related higher systemic choline levels to adverse cardiovascular risk, and even suggested